Showing 401 - 420 results of 735 for search '"Severe acute respiratory syndrome"', query time: 0.25s Refine Results
  1. 401

    Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing. by Lance D Eckerle, Michelle M Becker, Rebecca A Halpin, Kelvin Li, Eli Venter, Xiaotao Lu, Sana Scherbakova, Rachel L Graham, Ralph S Baric, Timothy B Stockwell, David J Spiro, Mark R Denison

    Published 2010-05-01
    “…We report here the engineering and recovery of nsp14-ExoN mutant viruses of severe acute respiratory syndrome coronavirus (SARS-CoV) that have stable growth defects and demonstrate a 21-fold increase in mutation frequency during replication in culture. …”
    Get full text
    Article
  2. 402

    Antiseptics: An expeditious third force in the prevention and management of coronavirus diseases by Kizito I. Okeke, Chukwuemeka Samson Ahamefule, Obianuju O. Nnabuife, Ibuchukwu N. Orabueze, Christian U. Iroegbu, Kingsley A. Egbe, Anthony C. Ike

    Published 2024-01-01
    “…Notably, severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS) and coronavirus disease 2019 (COVID-19) have all had significant negative impact on global health and economy. …”
    Get full text
    Article
  3. 403

    Socioeconomic Disparities in the Usage of Urban Opportunities in South Korea During the COVID-19 Pandemic: Using Land Use/Land Cover and Mobile Phone Data by Kangjae Lee, Yoo Min Park, Yoohyung Joo, Minsoo Joo, Joon Heo

    Published 2024-11-01
    “…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 19 (COVID-19), has resulted in dramatic changes in human lifestyles and the geographic distribution of populations. …”
    Get full text
    Article
  4. 404

    Immune-Boosting and Antiviral Effects of Antioxidants in COVID-19 Pneumonia: A Therapeutic Perspective by Stefano Sanduzzi Zamparelli, Alessandro Sanduzzi Zamparelli, Marialuisa Bocchino

    Published 2025-01-01
    “…The COVID-19 pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has profoundly impacted global health, with pneumonia emerging as a major complication in severe cases. …”
    Get full text
    Article
  5. 405

    Frequency and Distribution of Parasites Detected in Children Between 2017-2022 (6-year Period) by Yelda Sorguç

    Published 2024-12-01
    “…We believe that infection control measures and strict enforcement of quarantine rules to reduce the spread of severe acute respiratory syndrome-coronavirus-2 may have significantly reduced the parasite positivity rate during the pandemic period. …”
    Get full text
    Article
  6. 406

    COVID-19 Pathophysiology: Inflammation to Cardiac Injury by Sami Fouda, Robert Hammond, Peter D Donnelly, Anthony R M Coates, Alexander Liu

    Published 2024-12-01
    “…The causative virus, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), can invade host cells in multiple organs by binding the angiotensin-converting enzyme (ACE) II expressed on the cell surface. …”
    Get full text
    Article
  7. 407

    Influence of Fasting Plasma Glucose Level on Admission of COVID-19 Patients: A Retrospective Study by Yingying Zhao, Huichun Xing

    Published 2022-01-01
    “…Previous studies focused primarily on the relationship between blood glucose and mortality or severe outcomes, but there were few research studies on the relationship between fasting plasma glucose (FPG) and duration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA positive status. …”
    Get full text
    Article
  8. 408

    Origin and cross-species transmission of bat coronaviruses in China by Alice Latinne, Ben Hu, Kevin J. Olival, Guangjian Zhu, Li-Biao Zhang, Hongying Li, Aleksei A. Chmura, Hume E. Field, Carlos Zambrana-Torrelio, Jonathan H. Epstein, Bei Li, Wei Zhang, Lin-Fa Wang, Zheng-Li Shi, Peter Daszak

    Published 2024-12-01
    “…Abstract Bats are presumed reservoirs of diverse coronaviruses (CoVs) including progenitors of Severe Acute Respiratory Syndrome (SARS)-CoV and SARS-CoV-2, the causative agent of COVID-19. …”
    Get full text
    Article
  9. 409

    Validation of a Nepali version of the questionnaire to assess preventive practices against the COVID-19 pandemic in the general population by Dipsikha Aryal, Puspa Acharya, Niraj Bhattarai, Roshan Gwachha

    Published 2024-12-01
    “…Abstract Background The new coronavirus disease 2019 (COVID-19), caused by a virus in the coronavirus family called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Due to lack of effective treatment, the major way to breakdown the disease transmission is by application of preventive measures. …”
    Get full text
    Article
  10. 410

    The Impact of Severe COVID-19 Infection on Renal and Liver Markers (Urea, Creatinine, GOT, GPT) in Diabetic by Marwah Yones, Estabraq Alwasiti, Abdul Hameed Al-Qaseer, Anees Nile

    Published 2023-01-01
    “… Background: Coronavirus disease 2019 (COVID-19), an epidemic illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), affecting the lower respiratory tract. …”
    Get full text
    Article
  11. 411

    Strategies Used by SARS-CoV-2 to Evade the Innate Immune System in an Evolutionary Perspective by Hong Fan, Mingfu Tian, Siyu Liu, Chenglin Ye, Zhiqiang Li, Kailang Wu, Chengliang Zhu

    Published 2024-12-01
    “…By the end of 2019, the COVID-19 pandemic, resulting from the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), had diffused widely across the globe, with 770 million infected individuals and over 7 million deaths reported. …”
    Get full text
    Article
  12. 412

    Topic Modeling of Nursing Issues in the Media During 4 Emerging Infectious Disease Epidemics in South Korea: Descriptive Analysis by Jungok Kim, Eun Kyoung Yun

    Published 2025-01-01
    “…ObjectiveThe purpose of this study was to analyze and draw implications from changes in key nursing issues reported by the news media during the outbreaks of severe acute respiratory syndrome (SARS; 2003), influenza A (2009), Middle East respiratory syndrome (MERS; 2015), and COVID-19 (2020) in Korea using topic modeling. …”
    Get full text
    Article
  13. 413

    Insights into the Risk Factors and Outcomes of Post-COVID-19 Syndrome—Results from a Retrospective, Cross-Sectional Study in Romania by Ioana Bejan, Corneliu Petru Popescu, Simona Maria Ruta

    Published 2024-11-01
    “…Post-Coronavirus Disease 2019 (post-COVID-19) syndrome represents a cluster of persistent symptoms following Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection that can severely affect quality of life. …”
    Get full text
    Article
  14. 414

    Parkinson’s disease and other movement disorders in the context of the SARS-COV-2 pandemic by R. Kaladytė Lokominienė

    Published 2020-06-01
    “… Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is able to invade the human nervous system and can cause headache, nausea, vomiting, febrile seizures, encephalopathy, encephalitis, ataxia or psychiatric disorders, as well as quantitative disturbances of smell and taste which are observed both during the course of Parkinson’s disease and other alpha-synucleinopathies, only in slowly progressive and irreversible manner. …”
    Get full text
    Article
  15. 415

    Autoimmune hepatitis under the COVID-19 veil: an analysis of the nature of potential associations by Chaojie Yu, Wenrui Wang, Qian Zhang, Zhenjing Jin

    Published 2025-01-01
    “…In recent years, the novel coronavirus infectious disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has led to over 670 million infections and nearly 7 million deaths worldwide. …”
    Get full text
    Article
  16. 416

    Real-world use of multiplex point-of-care molecular testing or laboratory-based molecular testing for influenza-like illness in a 2021 to 2022 US outpatient sample. by Karen M Stockl, Jamie Tucker, Anne Beaubrun, Julia M Certa, Laura Becker, Jordan G Chase

    Published 2024-01-01
    “…While molecular testing is recommended for symptomatic patients suspected of having coronavirus disease 2019 (COVID-19), limited data are available examining real-world use of tests for severe acute respiratory syndrome coronavirus (SARS-CoV-2) and the impact of SARS-CoV-2 testing on patient outcomes. …”
    Get full text
    Article
  17. 417

    SARS-CoV-2 infection of domestic animals and their role in evolution and emergence of variants of concern by Olajumoke Olufunmilayo Joseph, Samuel Olatunde Dahunsi, Anthony Okoh

    Published 2024-12-01
    “…Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that is responsible for COVID-19 pandemic, is a zoonotic RNA virus that has been reported in animals, including domestic animals. …”
    Get full text
    Article
  18. 418

    Characterizing temporal and global host innate immune responses against SARS-CoV-1 and -2 infection in pathologically relevant human lung epithelial cells. by Vivian Y Tat, Aleksandra K Drelich, Pinghan Huang, Kamil Khanipov, Jason C Hsu, Steven G Widen, Chien-Te Kent Tseng, George Golovko

    Published 2025-01-01
    “…Severe acute respiratory syndrome coronavirus-1 (SARS-CoV-1) and -2 (SARS-CoV-2) are beta-coronaviruses (β-CoVs) that have caused significant morbidity and mortality worldwide. …”
    Get full text
    Article
  19. 419

    Deciphering the pathogen heterogeneity for precise diagnosis and personalized therapeutics of infections after kidney transplantation: insights from metagenomic next-generation seq... by Xin Ye, Yuxin Lin, Jiangnan Yang, Baocui Qi, Xuedong Wei, Yuhua Huang, Liangliang Wang

    Published 2024-11-01
    “…The pathogens commonly identified in kidney transplant patients were severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), followed by Pneumocystis jirovecii and Cytomegalovirus (CMV). mNGS guided the precise clinical diagnosis in 89.13% of cases and assisted in altering therapeutics from empirical antibiotic approaches to personalized plans in 56.10% of cases, including treatment escalation (40.65%), initiation (11.38%), drug adjustment (3.25%), and de-escalation (0.81%).DiscussionOur study demonstrated the superior detection performance of mNGS and its significant clinical value. …”
    Get full text
    Article
  20. 420

    A Study on Coronavirus Disease-2019 Stigma Associated with Coronavirus Disease-2019 Warriors and an Insight into Community Perception by Madhavi GAJULA, Suwarna MADHUKUMAR

    Published 2022-03-01
    “…Objective: In 2020, the world came to a standstill due to the havoc created by severe acute respiratory syndrome coronavirus-2. The onus of tackling the disease relies largely on healthcare workers. …”
    Get full text
    Article